Envirotainer invests in Swiss Airtainer to accelerate sustainable innovation in pharmaceutical cold chain

▤ Summary

Envirotainer has invested in Swiss Airtainer to expand its sustainable cold chain portfolio for temperature-sensitive pharmaceuticals. The deal gives Envirotainer exclusive global rights to offer Swiss Airtainer’s lightweight container technology. Swiss Airtainer will use the partnership to scale production and accelerate research and development. The companies position the agreement as a step toward lower-emission logistics and stronger sustainability performance across pharmaceutical transport.

▦ Linked Companies